Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-25-001664
Filing Date
2025-06-02
Accepted
2025-06-02 20:03:26
Documents
1
Period of Report
2025-05-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form412927027_06022025.html 4  
1 OWNERSHIP DOCUMENT form412927027_06022025.xml 4 3442
  Complete submission text file 0000921895-25-001664.txt   4955
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Issuer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 NORTH MAIN STREET SUITE 301 ALPHARETTA GA 30009
Business Address
Liu Da David (Reporting) CIK: 0002054265 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37619 | Film No.: 251016876